Atopic Dermatitis, Cutaneous T-cell Lymphoma, Eczema, Mycosis Fungoides, Sezary Syndrome
Conditions
Keywords
Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides, Blood/tissue banking, eczema, atopic dermatitis
Brief summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Detailed description
The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor: * immunologic assays/flow cytometry * tumor progression/regression * genomic studies * proteomic studies * others germane to the advancement of CTCL treatment
Interventions
OTHERBlood draw, skin biopsy or urine collection
Up to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.
Sponsors
University of Pittsburgh
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 or older * able and willing to provide informed consent * diagnosed with CTCL * diagnosed with either atopic dermatitis or eczema
Exclusion criteria
* Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proteomics of Cutaneous T-cell lymphoma | Ongoing | Proteomic variables will be measured in blood and tissue of consented CTCL patients. |
Countries
United States
Contacts
Primary ContactCharity L Ruhl, LPN
Outcome results
None listed